IRLAB-AIRLAB Therapeutics AB (publ)
STO · SE · Healthcare · Biotechnology · irlab.se
1.718SEK+0.12%Mkt Cap: 24.07M $P/E:

IRLAB Therapeutics AB (publ) discovers and develops drugs for the treatment of Parkinson's disease and other central nervous system (CNS) disorders in the United States. The company develops Mesdopetam (IRL790), which ha…